Discover. Scale. Harvest.
Meet the only adherent, perfusion-based bioreactor platform that scales down to speed you up.
Optimize your processes for cell therapy, extracellular vesicle, and viral vector manufacturing while saving development time and mitigating scalability cost and efficiency.
From Bench to Commercial Scale.
We’ve been through the bottlenecks ourselves. That’s why we designed Exo-Harvest to scale smarter, from the ground up.
Traditional systems limit scalability for adherent cell lines.
Exo-Harvest's modular bioreactor technology breaks free from these constraints.
Exo-Harvest uniquely enables realistic small-scale experiments, cutting costs and resource demands before seamlessly scaling up to larger systems.
"For instance, if traditional development takes a minimum of 12 months, by using Exo-Harvest, we can start at very small scale and parallelize multiple experiments 6x faster and 10x cheaper then the conventional approach."
Don't limit yourself to bigger. It isn't always better.
Small-Scale Feasibility
Our high-throughput system enables the parallelization of experiments by multiples of six, and accelerates research with rapid screening capabilities.
Pilot or Mid-Scale Process Validation
A modular, mid-scale bioreactor for process refinement and validation.
High-Volume, Small Footprint
A bioreactor capable of large-scale, homogeneous perfusion for reliable, high-yield commercial manufacturing of adherent cell-based products.
Transforming Tomorrow's Adherent Cell-Derived Therapies
Optimize culture conditions and enhance purification methods.
Exo-Harvest delivers high-performance adherent cell culture for the most demanding applications in modern bioproduction. Whether you're engineering cells for therapy, producing viral vectors for gene delivery, or harvesting extracellular vesicles, our platform offers the control, consistency, and throughput needed to drive innovation forward.
From early-stage discovery to late-stage process refinement, Exo-Harvest empowers your team with the tools to produce better biologics, faster.
Extracellular Vesicle Production
Maximize yields and purity with gentle, continuous harvesting and optimized media flow. Create high-quality therapeutic or diagnostic extracellular vesicles with reduced variability.
Gene Therapy
Boost AAV and lentiviral vector output with precise environmental control. Maintain consistent cell conditions to improve productivity, reproducibility, and downstream processing of viral vectors.
Cell Therapy
Expand adherent cell populations efficiently and reliably. Exo-Harvest ensures uniform growth conditions, enabling high-viability cultures ready for further engineering or therapeutic use.
Optimize Your Path to Commercialization.
Downscale your discovery for cell therapy, viral vector manufacturing, and exocellular vesicle production. Control and monitor parallel small-scale bioreactors to reduce costs, speed up iteration, and test more conditions faster and with fewer resources.
Downscale Your Discovery
Our high-throughput system enables the parallelization of experiments by multiples of six, and accelerates research with rapid screening capabilities.
Seamlessly Scale Up
Transition confidently from bench scale to GMP-ready production with systems designed to meet regulatory requirements.
Slash Costs From Discovery to Commercialization
Lower labor, media, and infrastructure requirements. Parallel runs and optimized processes ensure up to 10× higher yields than conventional methods in less space.
Built-In Control
Customized integrated sensors and automated PID control loop ensure batch-to-batch consistency and high-quality results.
Unlock Scalable Bioproduction with Exo-Harvest
Together, we can accelerate your breakthrough and shape the future of biologic manufacturing.